Acetylon Pharmaceuticals is pursuing development of next-generation, selective histone deacetylase (HDAC) enzyme inhibitors with potential for treatment of hematologic and solid tumor cancers, inflammatory diseases such as rheumatoid arthritis, neurodegenerative diseases such as Parkinson's, genetic diseases incluidng sickle cell disease and thalassemia major, and infectious disease such as malaria. Acetylon's technology is being licensed from Harvard University and the Dana Farber Cancer Center. Acetylon raised $7.25M in a Series A finanicng involving private investors including The Kraft Group in July 2009.
Company Details
- Phone
- (617) 245-1300
- in****@****lon.com
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- acetylon.com
- Keywords
- Miami.
Acetylon Pharmaceuticals, Inc. Questions
Acetylon Pharmaceuticals, Inc.'s helpline number is (617) 245-1300
Acetylon Pharmaceuticals, Inc.'s website is acetylon.com
Acetylon Pharmaceuticals, Inc.'s LinkedIn profile is https://www.linkedin.com/company/acetylon-pharmaceuticals-inc.
Acetylon Pharmaceuticals, Inc.'s industry is
Pharmaceutical Manufacturing
Acetylon Pharmaceuticals, Inc.'s top competitors are
Regenacy Pharmaceuticals, Inc.,
Tolero Pharmaceuticals, Inc.,
Polaryx Therapeutics,
Tsumura & Co.,
Actimis Pharmaceuticals,
Antagen Pharmaceuticals, Covid-19 Testing Products,
Alexion Pharmaceuticals, Inc.,
Affymax Research Institute,
Vitae Pharmaceuticals,
Advanced Pharma - Miami.
Acetylon Pharmaceuticals, Inc.'s support email address is info@acetylon.com
Acetylon Pharmaceuticals, Inc.'s categories are Pharmaceutical Manufacturing
